FIELD: medicine, pharmaceutical industry, pharmacy. SUBSTANCE: invention relates to drugs containing recombinant interferon. Antiviral agent containing recombinant alpha-, beta- or gamma-interferon has additionally stabilizing agent of biological, physical-chemical properties and/or resistance to bacterial contamination and consistent-forming base at the following ratio of components, in 1 g of mixture: recombinant interferon, 500-5000000 IU; stabilizing agent, 0.0001-0.4 g and consistent-forming base, the balance. Invention provides the development of preparation with prolonged effect, good penetrating capability, antiviral, antibacterial, anti-inflammatory, detoxificating, topical anesthetizing and regenerating effects. EFFECT: enhanced effectiveness of agent, valuable curative properties. 9 cl, 7 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| ANTIVIRUS MEANS IN LIPOSOME FORM | 2000 | 
 | RU2176518C1 | 
| ANTIVIRAL AGENT | 2000 | 
 | RU2187330C1 | 
| CONDOM LUBRICANT | 2000 | 
 | RU2187329C1 | 
| CURATIVE AGENT | 2000 | 
 | RU2187332C1 | 
| ANTIVIRAL AGENT - EYE DROPS "OFTALMOFERON" | 1999 | 
 | RU2140286C1 | 
| ANTIVIRAL, ANTIBACTERIAL AND ANTICANDIDOSIS AGENT | 2000 | 
 | RU2187328C1 | 
| INTRANASAL AGENT | 2002 | 
 | RU2220739C1 | 
| ANTIVIRAL AGENT - NASAL DROPS "GRIPPFERON" | 1999 | 
 | RU2140285C1 | 
| ANTIVIRAL AGENT - EYE DROPS | 2012 | 
 | RU2473363C1 | 
| PHARMACEUTICAL COMPOSITION IN FORM OF CAPSULE POSSESSING ANTIVIRAL, ANTI-INFLAMMATORY, ANTIMICROBIAL AND IMMUNOMODULATORY ACTION | 2012 | 
 | RU2482872C1 | 
Authors
Dates
2000-06-10—Published
1999-05-17—Filed